Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397319 · ClinicalTrials.gov registry record
Growth Hormone's Effect on the Cardiovascular System
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 26
- Enrollment target
NCT00397319 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 26 participants.
The verdict
NCT00397319 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
To evaluate specific markers of cardiovascular risk before and after growth hormone replacement therapy in a population of growth hormone deficient adults, as compared to an age, gender, and BMI-matched healthy population.
Interventions
- DRUG Growth Hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00397319
The ClinicalTrials.gov registry entry for NCT00397319 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Growth Hormone is the first listed.
NCT00397319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00397319 about?
NCT00397319 is a clinical study titled "Growth Hormone's Effect on the Cardiovascular System". To evaluate specific markers of cardiovascular risk before and after growth hormone replacement therapy in a population of growth hormone deficient adults, as compared to an age, gender, and BMI-matched healthy population.
What is the current status of trial NCT00397319?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2005-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00397319?
The interventions under investigation include: Growth Hormone (DRUG).
Who is sponsoring clinical trial NCT00397319?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.